In AD, the caudate nucleus head demonstrated elevated Drp-1 (p ≤ 0.0001) and Mfn-2 (p ≤ 0.0001) levels, and decreased Opa-1 levels (p ≤ 0.0001) compared to aging cases (Figure 6). This evidence concerns the gene MFN2 and Alzheimer disease.